⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

RPRX

Royalty Pharma plc

Healthcare · Biotechnology

60.59USD

+0.0000 (+0.00%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 60.59
P/E43.0
Dvd Ind Yld1.5%
P/B3.58
P/S13.8
Curr EV/T12M EBITDA25.1
Mkt Cap (USD)35.0B
Curr EV (USD)38.1B
2)

Per Share Data

EPS T12M1.76
DPS0.94
Bk Val Per Sh15.33
Rev/Sh4.55
Cash/Sh1.88
Curr Shares Out445.3M
FCF/Sh-2.15
3)

Cash Flow Analysis

P/CF11.8
Curr P/FCF-29.3
CF/NI3.7
Dvd P/O48.9%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales117.4%
Eff Interest Rate4.3%
4)

Growth Potential

Dil EPS 1Y Gr-6.8%
Cap 1Y Gr4.0%
BPS 1Y Gr-1.1%
R&D To Sales9.4%
Retention Rate51.1%
Rev 1Y Gr5.1%
FCF 1Y Gr—
Assets 1Y Gr7.7%
5)

Profitability

EBITDA1.5B
EBIT1.5B
Operating Margin59.6%
Pretax Margin53.2%
Net Margin32.1%
ROA4.3%
ROE8.5%
ROC8.1%
Asset Turnover0.13
6)

Structure

Current Ratio2.80
Quick Ratio2.79
Debt/Assets45.2%
Debt/Com Eq91.6%
Net Debt/EBITDA5.37
Tot Debt/Capital47.8%
Gross Margin95.8%
EBIT/Int Exp4.2

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.